Pfizer’s Results, What’s Next for Retail & Restaurants, The High Bar for CRISPR & More

Pfizer’s Results, What’s Next for Retail & Re...

Up next

Is SoundHound Stock (SOUN) About to Short Squeeze? | 7investing Live

Simon Erickson breaks down how a short squeeze works and why SoundHound AI stock (NASDAQ: SOUN) may be setting up for one right now. Learn what short interest and days-to-cover really mean, how these metrics predicted Upstart Holdings' (NASDAQ: UPST) 220% run in 2023, and why Sou ...  Show more

Small Caps Are Crushing the S&P 500 in 2026 | Russell 2000's Best Start Since 1991 | 7investing Live

Everyone calls the S&P 500 "the market." But is it really? In this episode of 7investing Live, founder and CEO Simon Erickson breaks down what the market actually is in 2026, and why the benchmark you're using matters more than you think. There are roughly 5,600 companies listed ...  Show more

Recommended Episodes

A Vaccine Boost
Motley Fool Hidden Gems Investing

Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason ...  Show more

Market Reaction to COVID Lockdowns and Developments, a Record High for the Nasdaq, The EV Space’s Week for the Ages and the House Passes Pres. Biden's $1.7T Social Spending Package
Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discussed market worries about COVID-19, with Austria announcing a nationwide lockdown while Germany tried to tamp down fears that it would follow suit. But in the U.S., FDA authorized use of Pfizer and Moderna's COVID vaccine booster ...  Show more

COVID-19 Vaccine Optimism, Business Leaders' Message To President Trump, And Retail Stocks' Big November Rally
Squawk on the Street

Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no ser ...

  Show more

Record Highs, Coronavirus Concerns, Facebook’s New Hobby
Motley Fool Hidden Gems Investing

Nvidia shakes off its “crypto hangover” and reports blowout earnings. Shopify soars. Pepsi surprises. And Roku rises. Motley Fool analysts Emily Flippen, Ron Gross, and Jason Moser discuss those stories and weigh in on the latest from Mattel, Lyft, Under Armour, and Restaurant Br ...  Show more